US Stock MarketDetailed Quotes

CHRS Coherus BioSciences

Watchlist
  • 1.295
  • +0.205+18.81%
Trading Nov 25 12:29 ET
149.20MMarket Cap-14388P/E (TTM)

Coherus BioSciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
-5.09%70.77M
10.67%64.98M
137.58%77.06M
21.89%257.24M
101.81%91.52M
64.16%74.57M
-2.39%58.72M
-46.04%32.44M
-35.37%211.04M
-38.19%45.35M
Operating revenue
-5.09%70.77M
0.03%58.47M
137.58%77.06M
21.89%257.24M
101.81%91.52M
64.16%74.57M
-2.82%58.46M
-46.04%32.44M
-35.37%211.04M
-38.19%45.35M
Cost of revenue
-36.58%20.74M
14.17%28.37M
104.97%34.59M
126.86%158.99M
495.46%84.57M
-7.18%32.7M
120.34%24.85M
80.09%16.87M
21.69%70.08M
17.33%14.2M
Gross profit
19.51%50.03M
8.10%36.61M
172.95%42.48M
-30.30%98.25M
-77.67%6.96M
310.84%41.87M
-30.70%33.87M
-69.33%15.56M
-47.59%140.96M
-49.16%31.15M
Operating expense
-23.62%56.42M
-16.50%57.12M
2.03%85M
-24.23%301.45M
-8.21%75.86M
-18.50%73.87M
-26.35%68.41M
-36.73%83.31M
-25.33%397.84M
-18.02%82.64M
Selling and administrative expenses
-27.95%34.74M
-22.10%35.17M
15.01%56.53M
-3.26%192.02M
-7.70%49.49M
7.57%48.22M
-11.96%45.14M
0.82%49.15M
16.95%198.48M
7.13%53.62M
Research and development costs
-15.48%21.68M
-5.64%21.96M
-16.64%28.47M
-45.11%109.44M
-9.14%26.37M
-44.01%25.65M
-44.08%23.27M
-58.81%34.15M
-45.10%199.36M
-42.83%29.02M
Operating profit
80.04%-6.39M
40.63%-20.51M
37.23%-42.53M
20.90%-203.2M
-33.81%-68.91M
60.22%-32.01M
21.52%-34.54M
16.29%-67.75M
2.64%-256.88M
-30.21%-51.49M
Net non-operating interest income expense
47.78%-5.36M
46.35%-5.33M
-14.46%-11.12M
-24.84%-40.54M
-13.15%-10.62M
-36.18%-10.27M
-51.11%-9.94M
-8.28%-9.71M
-41.44%-32.47M
-62.01%-9.39M
Non-operating interest expense
-47.78%5.36M
-46.35%5.33M
14.46%11.12M
24.84%40.54M
13.15%10.62M
36.18%10.27M
51.11%9.94M
8.28%9.71M
41.44%32.47M
62.01%9.39M
Other net income (expense)
-55.70%998K
699.13%12.92M
8,957.64%156.52M
327.88%5.47M
-106.42%-129K
68.26%2.25M
265.01%1.62M
127.92%1.73M
-748.06%-2.4M
621.56%2.01M
Special income (charges)
---1.09M
--11.46M
--153.65M
--0
--0
--0
--0
--0
---6.22M
--0
-Less:Other special charges
----
--12.63M
----
----
----
----
----
----
--6.22M
--0
-Gain on sale of business
---1.09M
--24.09M
--153.65M
----
----
--0
--0
--0
----
----
Other non- operating income (expenses)
-7.50%2.08M
-9.28%1.47M
66.03%2.87M
43.09%5.47M
-106.42%-129K
68.26%2.25M
265.01%1.62M
5,300.00%1.73M
1,450.53%3.82M
621.56%2.01M
Income before tax
73.14%-10.75M
69.86%-12.92M
235.85%102.88M
18.33%-238.27M
-35.30%-79.65M
53.81%-40.02M
14.52%-42.87M
21.18%-75.73M
-1.62%-291.75M
-28.75%-58.87M
Income tax
0
0
0
-380K
0
-380K
0
0
0
0
Net income
72.88%-10.75M
69.86%-12.92M
235.85%102.88M
18.46%-237.89M
-35.30%-79.65M
54.25%-39.64M
14.52%-42.87M
21.18%-75.73M
-1.62%-291.75M
-28.75%-58.87M
Net income continuous Operations
72.88%-10.75M
69.86%-12.92M
235.85%102.88M
18.46%-237.89M
-35.30%-79.65M
54.25%-39.64M
14.52%-42.87M
21.18%-75.73M
-1.62%-291.75M
-28.75%-58.87M
Minority interest income
Net income attributable to the parent company
72.88%-10.75M
69.86%-12.92M
235.85%102.88M
18.46%-237.89M
-35.30%-79.65M
54.25%-39.64M
14.52%-42.87M
21.18%-75.73M
-1.62%-291.75M
-28.75%-58.87M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
72.88%-10.75M
69.86%-12.92M
235.85%102.88M
18.46%-237.89M
-35.30%-79.65M
54.25%-39.64M
14.52%-42.87M
21.18%-75.73M
-1.62%-291.75M
-28.75%-58.87M
Basic earnings per share
78.05%-0.09
77.55%-0.11
194.79%0.91
32.71%-2.53
6.58%-0.71
63.06%-0.41
24.62%-0.49
22.58%-0.96
1.31%-3.76
-26.67%-0.76
Diluted earnings per share
78.05%-0.09
77.55%-0.11
186.46%0.83
32.71%-2.53
6.58%-0.71
63.06%-0.41
24.62%-0.49
22.58%-0.96
1.31%-3.76
-26.67%-0.76
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue -5.09%70.77M10.67%64.98M137.58%77.06M21.89%257.24M101.81%91.52M64.16%74.57M-2.39%58.72M-46.04%32.44M-35.37%211.04M-38.19%45.35M
Operating revenue -5.09%70.77M0.03%58.47M137.58%77.06M21.89%257.24M101.81%91.52M64.16%74.57M-2.82%58.46M-46.04%32.44M-35.37%211.04M-38.19%45.35M
Cost of revenue -36.58%20.74M14.17%28.37M104.97%34.59M126.86%158.99M495.46%84.57M-7.18%32.7M120.34%24.85M80.09%16.87M21.69%70.08M17.33%14.2M
Gross profit 19.51%50.03M8.10%36.61M172.95%42.48M-30.30%98.25M-77.67%6.96M310.84%41.87M-30.70%33.87M-69.33%15.56M-47.59%140.96M-49.16%31.15M
Operating expense -23.62%56.42M-16.50%57.12M2.03%85M-24.23%301.45M-8.21%75.86M-18.50%73.87M-26.35%68.41M-36.73%83.31M-25.33%397.84M-18.02%82.64M
Selling and administrative expenses -27.95%34.74M-22.10%35.17M15.01%56.53M-3.26%192.02M-7.70%49.49M7.57%48.22M-11.96%45.14M0.82%49.15M16.95%198.48M7.13%53.62M
Research and development costs -15.48%21.68M-5.64%21.96M-16.64%28.47M-45.11%109.44M-9.14%26.37M-44.01%25.65M-44.08%23.27M-58.81%34.15M-45.10%199.36M-42.83%29.02M
Operating profit 80.04%-6.39M40.63%-20.51M37.23%-42.53M20.90%-203.2M-33.81%-68.91M60.22%-32.01M21.52%-34.54M16.29%-67.75M2.64%-256.88M-30.21%-51.49M
Net non-operating interest income expense 47.78%-5.36M46.35%-5.33M-14.46%-11.12M-24.84%-40.54M-13.15%-10.62M-36.18%-10.27M-51.11%-9.94M-8.28%-9.71M-41.44%-32.47M-62.01%-9.39M
Non-operating interest expense -47.78%5.36M-46.35%5.33M14.46%11.12M24.84%40.54M13.15%10.62M36.18%10.27M51.11%9.94M8.28%9.71M41.44%32.47M62.01%9.39M
Other net income (expense) -55.70%998K699.13%12.92M8,957.64%156.52M327.88%5.47M-106.42%-129K68.26%2.25M265.01%1.62M127.92%1.73M-748.06%-2.4M621.56%2.01M
Special income (charges) ---1.09M--11.46M--153.65M--0--0--0--0--0---6.22M--0
-Less:Other special charges ------12.63M--------------------------6.22M--0
-Gain on sale of business ---1.09M--24.09M--153.65M----------0--0--0--------
Other non- operating income (expenses) -7.50%2.08M-9.28%1.47M66.03%2.87M43.09%5.47M-106.42%-129K68.26%2.25M265.01%1.62M5,300.00%1.73M1,450.53%3.82M621.56%2.01M
Income before tax 73.14%-10.75M69.86%-12.92M235.85%102.88M18.33%-238.27M-35.30%-79.65M53.81%-40.02M14.52%-42.87M21.18%-75.73M-1.62%-291.75M-28.75%-58.87M
Income tax 000-380K0-380K0000
Net income 72.88%-10.75M69.86%-12.92M235.85%102.88M18.46%-237.89M-35.30%-79.65M54.25%-39.64M14.52%-42.87M21.18%-75.73M-1.62%-291.75M-28.75%-58.87M
Net income continuous Operations 72.88%-10.75M69.86%-12.92M235.85%102.88M18.46%-237.89M-35.30%-79.65M54.25%-39.64M14.52%-42.87M21.18%-75.73M-1.62%-291.75M-28.75%-58.87M
Minority interest income
Net income attributable to the parent company 72.88%-10.75M69.86%-12.92M235.85%102.88M18.46%-237.89M-35.30%-79.65M54.25%-39.64M14.52%-42.87M21.18%-75.73M-1.62%-291.75M-28.75%-58.87M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 72.88%-10.75M69.86%-12.92M235.85%102.88M18.46%-237.89M-35.30%-79.65M54.25%-39.64M14.52%-42.87M21.18%-75.73M-1.62%-291.75M-28.75%-58.87M
Basic earnings per share 78.05%-0.0977.55%-0.11194.79%0.9132.71%-2.536.58%-0.7163.06%-0.4124.62%-0.4922.58%-0.961.31%-3.76-26.67%-0.76
Diluted earnings per share 78.05%-0.0977.55%-0.11186.46%0.8332.71%-2.536.58%-0.7163.06%-0.4124.62%-0.4922.58%-0.961.31%-3.76-26.67%-0.76
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data